Quantitative evaluation of PpSP15-LmSTI1 fusion gene expression following transfection with an alphavirus-derived self-amplifying mRNA and conventional DNA vaccine platforms

Mol Cell Probes. 2021 Oct:59:101749. doi: 10.1016/j.mcp.2021.101749. Epub 2021 Jun 30.

Abstract

New vaccine platforms are crucial to address complex parasitic infections such as cutaneous leishmaniasis. Self-amplifying mRNA (SAM) based vaccines represent the next generation nucleic acid-based platform. In the present study, we compared the expression levels of PpSP15-LmSTI1 fusion gene in BHK-21 cells following transfection with Semliki Forest virus (SFV)-derived SAM, SFV-derived plasmid DNA (pSFV-PD) and conventional plasmid DNA (pcDNA3.1+). PpSP15-LmSTI1 fusion gene expression levels were evaluated at different time points, using quantitative Real-time PCR. All data were validated and normalized by two internal control genes. According to the results, mean values of relative expression were significantly higher for SFV-PD SAM/fusion than pcDNA/fusion and pSFV-PD/fusion at all concentrations and time points. Our results showed that higher levels of PpSp15-LmSTI1 antigen expression could be achieved using a SAM vector than pcDNA and pSFV-PD, making it a valuable and efficient alternative to conventional plasmid DNA-based vaccines against leishmaniasis.

Keywords: Fusion; Gene expression; Plasmid DNA; PpSP15-LmSTI1; Self-amplifying mRNA; Vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alphavirus* / genetics
  • Gene Expression
  • RNA, Messenger / genetics
  • Transfection
  • Vaccines, DNA* / genetics

Substances

  • RNA, Messenger
  • Vaccines, DNA